Treatment with hederagenin in lung cancer cells, leads to a strong upregulation of the CHAC1 gene even though basal CHAC1 expression is significantly lower than in normal tissues (Lu et al., 2024). The gene discussed is CHAC1; the disease is lung carcinoma.